These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 230881)

  • 1. In vivo antagonism of analgesia and respiratory depression induced by proposed mu and kappa opiate agonists [proceedings].
    Metcalf G; Rees JM; Ward SJ
    Br J Pharmacol; 1979 Jul; 66(3):473P-474P. PubMed ID: 230881
    [No Abstract]   [Full Text] [Related]  

  • 2. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.
    Iyengar S; Kim HS; Wood PL
    J Pharmacol Exp Ther; 1986 Aug; 238(2):429-36. PubMed ID: 3016237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of opioids.
    Martin WR
    Pharmacol Rev; 1983 Dec; 35(4):283-323. PubMed ID: 6144112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A kappa opioid effect: increased urination in the rat.
    Leander JD
    J Pharmacol Exp Ther; 1983 Jan; 224(1):89-94. PubMed ID: 6294284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple opioid receptor systems in brain and spinal cord: Part 2.
    Yaksh TL
    Eur J Anaesthesiol; 1984 Sep; 1(3):201-43. PubMed ID: 6152614
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression.
    Shook JE; Watkins WD; Camporesi EM
    Am Rev Respir Dis; 1990 Oct; 142(4):895-909. PubMed ID: 2171388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A steric theory of opioid agonists, antagonists, agonist-antagonists, and partial agonists.
    Martin WR
    NIDA Res Monogr; 1984 Mar; 49():16-23. PubMed ID: 6090916
    [No Abstract]   [Full Text] [Related]  

  • 8. Further study of kappa opioids on increased urination.
    Leander JD
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
    Schmauss C; Yaksh TL
    J Pharmacol Exp Ther; 1984 Jan; 228(1):1-12. PubMed ID: 6319664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
    Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid receptor selectivity of heroin given intracerebroventricularly differs in six strains of inbred mice.
    Rady JJ; Elmer GI; Fujimoto JM
    J Pharmacol Exp Ther; 1999 Feb; 288(2):438-45. PubMed ID: 9918543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Place-conditioning properties of mu, kappa, and sigma opioid agonists.
    Iwamoto ET
    Alcohol Drug Res; 1985-1986; 6(5):327-39. PubMed ID: 3011025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective kappa opioid agonist for spinal analgesia without the risk of respiratory depression.
    Castillo R; Kissin I; Bradley EL
    Anesth Analg; 1986 Apr; 65(4):350-4. PubMed ID: 3006552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of norepinephrine release from rat cortex slices by opioids: differences among agonists in sensitivities to antagonists suggest receptor heterogeneity.
    Kim KW; Cox BM
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1153-60. PubMed ID: 8263776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of kindled amygdaloid seizures by opiate agonists and antagonists.
    Albertson TE; Joy RM; Stark LG
    J Pharmacol Exp Ther; 1984 Mar; 228(3):620-7. PubMed ID: 6323675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent pA2 analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys.
    Butelman ER; France CP; Woods JH
    J Pharmacol Exp Ther; 1993 Jan; 264(1):145-51. PubMed ID: 8093721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of mu- and kappa-receptors by means of correlation of analgesic potency in vivo and receptor binding affinity in vitro of various opioid agonists.
    Ensinger HA; Stockhaus K; Merz H
    Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):649-53. PubMed ID: 6096651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone benzoylhydrazone (NalBzoH) analgesia.
    Paul D; Levison JA; Howard DH; Pick CG; Hahn EF; Pasternak GW
    J Pharmacol Exp Ther; 1990 Nov; 255(2):769-74. PubMed ID: 2173757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
    Fang FG; Fields HL; Lee NM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectivity of opioid agonists and antagonists for the various opioid receptor types.
    Takemori AE; Portoghese PS
    Psychopharmacol Bull; 1985; 21(3):464-5. PubMed ID: 2994158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.